Shea Alderete is a passionate and strategic entrepreneur with over 15 years of experience in the cannabis industry. Shea has focused on revolutionizing cannabis for the past decade to provide clean medicine from its extraction, using his technical background to produce premium cannabis product and employ cutting-edge technology at Gen X. Previously, Shea had a professional career in baseball and recognized that there was a gap in the market for anti-inflammatory medicines for pain relief. Shea has long term experience working with reputable brands in the cannabis industry such as Moxie and HTH, where he set the innovative standard for cannabis extraction and paved the way for their success. He has won numerous cannabis product awards with the Cloud Vapes brand, which today is a $70M USD-a-year profitable business. In addition to this, Shea has won the Chalice Cup of California for the best CBD products as well as the Canada Karma Cup for the best vaporizer and terpenes in 2016.
GMR Executive Spotlight Q&A –
Full birth name: Shea Alderete
Title: Founder and CEO
Company: Gen X Biosciences
Years at current company: 4 years
Education profile: Bachelor’s degree in Business Marketing
Most successful professional accomplishment before cannabis: Played professional Baseball.
Company Mission: Gen X is consistently on the cutting edge of scalable production and delivers products that far exceed industry standards through its unique understanding of the chemistry and chemical processes involved in distillate extraction, coupled with access to the world’s best machinery and equipment. With the Company’s pending listing on the CSE and capital raise, Gen X is poised to be the leader in high-capacity and high-quality distillate production in California and beyond the Golden State.
Company’s most successful achievement: Gen X was the first ever cannabis brand to sponsor the 2016 X Games, giving Gen X national television exposure on ESPN and ABC as a sponsor of professional supercross star Tyler Bereman.
Has the company raised any capital (yes or no): Yes
If so, how much?: Gen X has raised $3 million to date.
Any plans on raising capital in the future? Yes, we are raising another $2-3 million.
Most important company 5 year goal: Gen X’s strategy to-date has been focused on utilizing cutting edge technology and our proprietary “molecular perfection” distillation process to produce premium cannabis products. The next five years will allow us to spread the platform, not only across the 50 states in the U.S., but internationally as well.
The post Executive Spotlight: Shea Alderete, Founder and CEO of Gen X Biosciences appeared first on Green Market Report.